A human lung xenograft mouse model of Nipah virus infection.

Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in humans with high mortality rates (up to 92%). NiV can cause Acute Lung Injury (ALI) in humans, and human-to-human transmission has been observed...

Full description

Bibliographic Details
Main Authors: Gustavo Valbuena, Hailey Halliday, Viktoriya Borisevich, Yenny Goez, Barry Rockx
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-04-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC3974875?pdf=render
_version_ 1818989312228720640
author Gustavo Valbuena
Hailey Halliday
Viktoriya Borisevich
Yenny Goez
Barry Rockx
author_facet Gustavo Valbuena
Hailey Halliday
Viktoriya Borisevich
Yenny Goez
Barry Rockx
author_sort Gustavo Valbuena
collection DOAJ
description Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in humans with high mortality rates (up to 92%). NiV can cause Acute Lung Injury (ALI) in humans, and human-to-human transmission has been observed in recent outbreaks of NiV. While the exact route of transmission to humans is not known, we have previously shown that NiV can efficiently infect human respiratory epithelial cells. The molecular mechanisms of NiV-associated ALI in the human respiratory tract are unknown. Thus, there is an urgent need for models of henipavirus infection of the human respiratory tract to study the pathogenesis and understand the host responses. Here, we describe a novel human lung xenograft model in mice to study the pathogenesis of NiV. Following transplantation, human fetal lung xenografts rapidly graft and develop mature structures of adult lungs including cartilage, vascular vessels, ciliated pseudostratified columnar epithelium, and primitive "air" spaces filled with mucus and lined by cuboidal to flat epithelium. Following infection, NiV grows to high titers (10(7) TCID50/gram lung tissue) as early as 3 days post infection (pi). NiV targets both the endothelium as well as respiratory epithelium in the human lung tissues, and results in syncytia formation. NiV infection in the human lung results in the production of several cytokines and chemokines including IL-6, IP-10, eotaxin, G-CSF and GM-CSF on days 5 and 7 pi. In conclusion, this study demonstrates that NiV can replicate to high titers in a novel in vivo model of the human respiratory tract, resulting in a robust inflammatory response, which is known to be associated with ALI. This model will facilitate progress in the fundamental understanding of henipavirus pathogenesis and virus-host interactions; it will also provide biologically relevant models for other respiratory viruses.
first_indexed 2024-12-20T19:36:28Z
format Article
id doaj.art-a6a12a7e7c9c4a3083514db866a4a376
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-20T19:36:28Z
publishDate 2014-04-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-a6a12a7e7c9c4a3083514db866a4a3762022-12-21T19:28:38ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742014-04-01104e100406310.1371/journal.ppat.1004063A human lung xenograft mouse model of Nipah virus infection.Gustavo ValbuenaHailey HallidayViktoriya BorisevichYenny GoezBarry RockxNipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in humans with high mortality rates (up to 92%). NiV can cause Acute Lung Injury (ALI) in humans, and human-to-human transmission has been observed in recent outbreaks of NiV. While the exact route of transmission to humans is not known, we have previously shown that NiV can efficiently infect human respiratory epithelial cells. The molecular mechanisms of NiV-associated ALI in the human respiratory tract are unknown. Thus, there is an urgent need for models of henipavirus infection of the human respiratory tract to study the pathogenesis and understand the host responses. Here, we describe a novel human lung xenograft model in mice to study the pathogenesis of NiV. Following transplantation, human fetal lung xenografts rapidly graft and develop mature structures of adult lungs including cartilage, vascular vessels, ciliated pseudostratified columnar epithelium, and primitive "air" spaces filled with mucus and lined by cuboidal to flat epithelium. Following infection, NiV grows to high titers (10(7) TCID50/gram lung tissue) as early as 3 days post infection (pi). NiV targets both the endothelium as well as respiratory epithelium in the human lung tissues, and results in syncytia formation. NiV infection in the human lung results in the production of several cytokines and chemokines including IL-6, IP-10, eotaxin, G-CSF and GM-CSF on days 5 and 7 pi. In conclusion, this study demonstrates that NiV can replicate to high titers in a novel in vivo model of the human respiratory tract, resulting in a robust inflammatory response, which is known to be associated with ALI. This model will facilitate progress in the fundamental understanding of henipavirus pathogenesis and virus-host interactions; it will also provide biologically relevant models for other respiratory viruses.http://europepmc.org/articles/PMC3974875?pdf=render
spellingShingle Gustavo Valbuena
Hailey Halliday
Viktoriya Borisevich
Yenny Goez
Barry Rockx
A human lung xenograft mouse model of Nipah virus infection.
PLoS Pathogens
title A human lung xenograft mouse model of Nipah virus infection.
title_full A human lung xenograft mouse model of Nipah virus infection.
title_fullStr A human lung xenograft mouse model of Nipah virus infection.
title_full_unstemmed A human lung xenograft mouse model of Nipah virus infection.
title_short A human lung xenograft mouse model of Nipah virus infection.
title_sort human lung xenograft mouse model of nipah virus infection
url http://europepmc.org/articles/PMC3974875?pdf=render
work_keys_str_mv AT gustavovalbuena ahumanlungxenograftmousemodelofnipahvirusinfection
AT haileyhalliday ahumanlungxenograftmousemodelofnipahvirusinfection
AT viktoriyaborisevich ahumanlungxenograftmousemodelofnipahvirusinfection
AT yennygoez ahumanlungxenograftmousemodelofnipahvirusinfection
AT barryrockx ahumanlungxenograftmousemodelofnipahvirusinfection
AT gustavovalbuena humanlungxenograftmousemodelofnipahvirusinfection
AT haileyhalliday humanlungxenograftmousemodelofnipahvirusinfection
AT viktoriyaborisevich humanlungxenograftmousemodelofnipahvirusinfection
AT yennygoez humanlungxenograftmousemodelofnipahvirusinfection
AT barryrockx humanlungxenograftmousemodelofnipahvirusinfection